Home/ Stocks/ CMPS

COMPASS Pathways Plc American Depository Shares

CMPS XNAS

$11.26 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$1.52B

About COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 156 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$91.20M	$0.71
FY 2025	$0	$-287,862,000	$-3.08
Q3 2025	$0	$-137,717,000	$-1.44
Q2 2025	$0	$-38,403,000	$-0.41

TickerDaily Coverage

Why Is Enveric Biosciences, Inc. Common Stock (ENVB) Stock Up 61.2% Today?

Market News Alex Chen · Apr 24, 2026

Enveric Biosciences stock exploded 61.2% to $6.71 on Friday, April 24, 2026, after President Trump...

View All Coverage →

Get CMPS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on COMPASS Pathways Plc American Depository Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.